
Baroda Bnp Paribas Mid Cap Fund Growth
Mutual Fund
Mid-Cap
Equity
India Growth
Growth Derivatives
Investor Profile1–7 yearsInvestment Horizon
HNI,Mass AffluentTarget Segments
SEBI registered equity mutual fund suitable for all investor categoriesRegulatory Fit
Performance and Risk Analysis
Historical returns, volatility patterns, and how this fund has performed relative to its benchmark.
Fund Performance
2.5% AnnuallyAlpha
12.9% vs 10.4% benchmarkSince Inception
14.0% vs 8.4% benchmark3Y Annualized
12.8% vs 7.0% benchmark5Y Annualized
Baroda Bnp Paribas Mid Cap Fund Growth
Benchmark Index
Benchmark Performance Comparison
Baroda BNP Paribas Mid Cap Fund
NIFTY 50
Given the product’s limited performance history, the assessment considers the fund house’s track record and the historical performance of comparable strategies managed by the same fund house, which follow similar investment approaches. Such comparisons provide historical context only and do not represent the performance of the new product or indicate its future returns.

Risk Profile
Standard Deviation16.6%
Beta0.84
Disclaimer: Mutual Fund Investments are subject to market risks, read all scheme related documents carefully. Past performance is not indicative of future results and there is no assurance that the scheme's objective will be achieved. Specialised Investment Funds (SIF) involve a higher degree of risk and a minimum investment of ₹10 Lakhs.
Strategy Details
A closer look at the investment thesis, portfolio construction, and current holdings.

Portfolio Holdings Overview
SectoralAllocation
Top Stock Holdings
CompanySectorAllocation
Clearing Corporation Of India Ltdothers7.50%
Hitachi Energy India Ltd Ordinary SharesIndustrials2.71%
GE Vernova T&D India LtdIndustrials2.62%
PB Fintech LtdFinancial Services2.47%
The Federal Bank LtdFinancial Services2.36%
Phoenix Mills LtdReal Estate2.34%
Indian BankFinancial Services2.31%
KPIT Technologies LtdTechnology2.19%
Bharat Heavy Electricals LtdIndustrials2.19%
Hindustan Petroleum Corp LtdEnergy2.12%
GlaxoSmithKline Pharmaceuticals LtdHealthcare2.11%
Firm Overview
AMCBaroda BNP Paribas Asset Management India Pvt. Ltd
Operational & Regulatory Details
What it costs to invest, transaction mechanics, and regulatory disclosures you should know.
Costs and Fees
Exit Load1%
Regulatory & Tax Information
INF251K01AW3
ISIN
DailyDealing Frequency
BSE Midcap TR INRBenchmark